TGFB1 and Miyoshi myopathy: The interplay between TGF-β and IL-6 was reported when both are expressed at high levels in MM bone marrow, which may affect the generation of Th17 cells both directly or via other pro-inflammatory cytokines, thereby modulating the antitumor immune responses [42].